A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy
Abstract
Mesoporous silica nanoparticles (MSNs) are promising drug carriers for use in cancer treatment owing to their excellent biocompatibility and drug‐loading capacity. However, MSN's incomplete drug release and toxic bioaccumulation phenomena limit their clinical application. Recently, researchers have presented redox responsive mesoporous organosilica nanoparticles containing disulfide (S–S) bridges (ss‐MONs). These nanoparticles retained their ability to undergo structural degradation and increased their local release activity when exposed to reducing agents. Disulfide‐based mesoporous organosilica nanoparticles offer researchers a better option for loading chemotherapeutic drugs due to their effective biodegradability through the reduction of glutathione. Although the potential of ss‐MONs in cancer theranostics has been studied, few researchers have systematically compared ss‐MONs with MSNs with regard to endocytosis, drug release, cytotoxicity, and therapeutic effect. In this work, ss‐MONs and MSNs with equal morphology and size were designed and used to payload doxorubicin hydrochloride (DOX) for liver cancer chemotherapy. The ss‐MONs showed considerable degradability in the presence of glutathione and performed comparably to MSNs on biocompatibility measures, including cytotoxicity and endocytosis, as well as in drug‐loading capacity. Notably, DOX‐loaded ss‐MONs exhibited higher intracellular drug release in cancer cells and better anticancer effects in comparison with DOX‐loaded MSNs. Hence, the ss‐MONs may be more desirable carriersmore »
- Authors:
-
- The Key Laboratory of Functional Molecular Solids Anhui Laboratory of Molecular‐Based Materials Ministry of Education Center for Nano Science and Technology College of Chemistry and Materials Science Anhui Normal University Wuhu China, CAS Key Laboratory of Bio‐Medical Diagnostics Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Suzhou China
- The Key Laboratory of Functional Molecular Solids Anhui Laboratory of Molecular‐Based Materials Ministry of Education Center for Nano Science and Technology College of Chemistry and Materials Science Anhui Normal University Wuhu China
- Jiangsu Key Laboratory of Oral Disease Department of Oral Implantology Affiliated Hospital of Stomatology Nanjing Medical University Nanjing China
- CAS Key Laboratory of Bio‐Medical Diagnostics Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Suzhou China
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1437056
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Chemical Biology & Drug Design
- Additional Journal Information:
- Journal Name: Chemical Biology & Drug Design Journal Volume: 92 Journal Issue: 2; Journal ID: ISSN 1747-0277
- Publisher:
- Wiley-Blackwell
- Country of Publication:
- United Kingdom
- Language:
- English
Citation Formats
Yue, Juan, Luo, Shi‐zhong, Lu, Meng‐meng, Shao, Dan, Wang, Zheng, and Dong, Wen‐fei. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy. United Kingdom: N. p., 2018.
Web. doi:10.1111/cbdd.13309.
Yue, Juan, Luo, Shi‐zhong, Lu, Meng‐meng, Shao, Dan, Wang, Zheng, & Dong, Wen‐fei. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy. United Kingdom. https://doi.org/10.1111/cbdd.13309
Yue, Juan, Luo, Shi‐zhong, Lu, Meng‐meng, Shao, Dan, Wang, Zheng, and Dong, Wen‐fei. Sat .
"A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy". United Kingdom. https://doi.org/10.1111/cbdd.13309.
@article{osti_1437056,
title = {A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy},
author = {Yue, Juan and Luo, Shi‐zhong and Lu, Meng‐meng and Shao, Dan and Wang, Zheng and Dong, Wen‐fei},
abstractNote = {Mesoporous silica nanoparticles (MSNs) are promising drug carriers for use in cancer treatment owing to their excellent biocompatibility and drug‐loading capacity. However, MSN's incomplete drug release and toxic bioaccumulation phenomena limit their clinical application. Recently, researchers have presented redox responsive mesoporous organosilica nanoparticles containing disulfide (S–S) bridges (ss‐MONs). These nanoparticles retained their ability to undergo structural degradation and increased their local release activity when exposed to reducing agents. Disulfide‐based mesoporous organosilica nanoparticles offer researchers a better option for loading chemotherapeutic drugs due to their effective biodegradability through the reduction of glutathione. Although the potential of ss‐MONs in cancer theranostics has been studied, few researchers have systematically compared ss‐MONs with MSNs with regard to endocytosis, drug release, cytotoxicity, and therapeutic effect. In this work, ss‐MONs and MSNs with equal morphology and size were designed and used to payload doxorubicin hydrochloride (DOX) for liver cancer chemotherapy. The ss‐MONs showed considerable degradability in the presence of glutathione and performed comparably to MSNs on biocompatibility measures, including cytotoxicity and endocytosis, as well as in drug‐loading capacity. Notably, DOX‐loaded ss‐MONs exhibited higher intracellular drug release in cancer cells and better anticancer effects in comparison with DOX‐loaded MSNs. Hence, the ss‐MONs may be more desirable carriers for a highly efficient and safe treatment of cancer.},
doi = {10.1111/cbdd.13309},
journal = {Chemical Biology & Drug Design},
number = 2,
volume = 92,
place = {United Kingdom},
year = {Sat May 12 00:00:00 EDT 2018},
month = {Sat May 12 00:00:00 EDT 2018}
}
https://doi.org/10.1111/cbdd.13309
Web of Science
Works referenced in this record:
Stimuli-responsive nanocarriers for drug delivery
journal, October 2013
- Mura, Simona; Nicolas, Julien; Couvreur, Patrick
- Nature Materials, Vol. 12, Issue 11
Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles
journal, January 2017
- Croissant, Jonas G.; Fatieiev, Yevhen; Khashab, Niveen M.
- Advanced Materials, Vol. 29, Issue 9
Janus Au–mesoporous silica nanocarriers for chemo-photothermal treatment of liver cancer cells
journal, January 2016
- Wang, Zheng; Wang, Yingshuai; Lu, Mengmeng
- RSC Advances, Vol. 6, Issue 50
Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells
journal, June 2016
- Croissant, Jonas G.; Fatieiev, Yevhen; Julfakyan, Khachatur
- Chemistry - A European Journal, Vol. 22, Issue 42
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
journal, February 2012
- Tang, Fangqiong; Li, Linlin; Chen, Dong
- Advanced Materials, Vol. 24, Issue 12
One-pot synthesis of redox-triggered biodegradable hybrid nanocapsules with a disulfide-bridged silsesquioxane framework for promising drug delivery
journal, January 2017
- Zhou, Mengyun; Du, Xin; Li, Weike
- Journal of Materials Chemistry B, Vol. 5, Issue 23
Intracellular pH-Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics
journal, September 2010
- Lee, Chia-Hung; Cheng, Shih-Hsun; Huang, I-Ping
- Angewandte Chemie International Edition, Vol. 49, Issue 44
Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications
journal, January 2015
- Imani, Rana; Emami, Shahriar Hojjati; Faghihi, Shahab
- Physical Chemistry Chemical Physics, Vol. 17, Issue 9
Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality
journal, May 2017
- Huang, Ping; Chen, Yu; Lin, Han
- Biomaterials, Vol. 125
Biodegradable Ethylene-Bis(Propyl)Disulfide-Based Periodic Mesoporous Organosilica Nanorods and Nanospheres for Efficient In-Vitro Drug Delivery
journal, July 2014
- Croissant, Jonas; Cattoën, Xavier; Man, Michel Wong Chi
- Advanced Materials, Vol. 26, Issue 35
Drug loaded and ethylcellulose coated mesoporous silica for controlled drug release prepared using a pilot scale fluid bed system
journal, June 2016
- Hacene, Youcef Chakib; Singh, Abhishek; Van den Mooter, Guy
- International Journal of Pharmaceutics, Vol. 506, Issue 1-2
Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release
journal, January 2010
- Chang, Baisong; Guo, Jia; Liu, Congying
- Journal of Materials Chemistry, Vol. 20, Issue 44
Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications
journal, April 2007
- Slowing, I. I.; Trewyn, B. G.; Giri, S.
- Advanced Functional Materials, Vol. 17, Issue 8
Breakable mesoporous silica nanoparticles for targeted drug delivery
journal, January 2016
- Maggini, Laura; Cabrera, Ingrid; Ruiz-Carretero, Amparo
- Nanoscale, Vol. 8, Issue 13
Role of 3-aminopropyltriethoxysilane in the preparation of mesoporous silica nanoparticles for ibuprofen delivery: Effect on physicochemical properties
journal, November 2013
- Kamarudin, N. H. N.; Jalil, A. A.; Triwahyono, S.
- Microporous and Mesoporous Materials, Vol. 180
Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite
journal, September 2015
- Hao, Xiaohong; Hu, Xixue; Zhang, Cuimiao
- ACS Nano, Vol. 9, Issue 10
Mechanistic insights on the reduction of glutathione disulfide by protein disulfide isomerase
journal, May 2017
- Neves, Rui P. P.; Fernandes, Pedro Alexandrino; Ramos, Maria João
- Proceedings of the National Academy of Sciences, Vol. 114, Issue 24
Improved controlled release of protein from expanded-pore mesoporous silica nanoparticles modified with co-functionalized poly(n-isopropylacrylamide) and poly(ethylene glycol) (PNIPAM-PEG)
journal, January 2017
- Yu, Erick; Lo, Allison; Jiang, Linda
- Colloids and Surfaces B: Biointerfaces, Vol. 149
Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
journal, July 2010
- Lu, Jie; Liong, Monty; Li, Zongxi
- Small, Vol. 6, Issue 16
Highly selective and sensitive detection of glutathione using mesoporous silica nanoparticles capped with disulfide-containing oligo(ethylene glycol) chains
journal, January 2015
- El Sayed, Sameh; Giménez, Cristina; Aznar, Elena
- Organic & Biomolecular Chemistry, Vol. 13, Issue 4
Redox-Responsive Polysulfide-Based Biodegradable Organosilica Nanoparticles for Delivery of Bioactive Agents
journal, June 2017
- Hadipour Moghaddam, Seyyed Pouya; Saikia, Jiban; Yazdimamaghani, Mostafa
- ACS Applied Materials & Interfaces, Vol. 9, Issue 25
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
journal, February 2009
- Park, Ji-Ho; Gu, Luo; von Maltzahn, Geoffrey
- Nature Materials, Vol. 8, Issue 4, p. 331-336
Biodegradability of sol–gel silica microparticles for drug delivery
journal, November 2008
- Finnie, Kim S.; Waller, Daniel J.; Perret, Francois L.
- Journal of Sol-Gel Science and Technology, Vol. 49, Issue 1
pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release
journal, December 2015
- Li, Qing-Lan; Xu, Shi-Han; Zhou, Hang
- ACS Applied Materials & Interfaces, Vol. 7, Issue 51
Janus “nano-bullets” for magnetic targeting liver cancer chemotherapy
journal, September 2016
- Shao, Dan; Li, Jing; Zheng, Xiao
- Biomaterials, Vol. 100
Preparation and characterization of porous hollow silica nanoparticles for drug delivery application
journal, February 2004
- Chen, Jian-Feng; Ding, Hao-Min; Wang, Jie-Xin
- Biomaterials, Vol. 25, Issue 4
Hollow Mesoporous Organosilica Nanoparticles: A Generic Intelligent Framework-Hybridization Approach for Biomedicine
journal, November 2014
- Chen, Yu; Meng, Qingshuo; Wu, Meiying
- Journal of the American Chemical Society, Vol. 136, Issue 46
A novel and automated assay for thiol/disulphide homeostasis
journal, December 2014
- Erel, Ozcan; Neselioglu, Salim
- Clinical Biochemistry, Vol. 47, Issue 18
Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release
journal, May 2016
- Hu, Jing-Jing; Xiao, Dong; Zhang, Xian-Zheng
- Small, Vol. 12, Issue 25
Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery
journal, June 2016
- Du, Xin; Li, Xiaoyu; Xiong, Lin
- Biomaterials, Vol. 91
Structure-Dependent and Glutathione-Responsive Biodegradable Dendritic Mesoporous Organosilica Nanoparticles for Safe Protein Delivery
journal, December 2016
- Yang, Yannan; Wan, Jingjing; Niu, Yuting
- Chemistry of Materials, Vol. 28, Issue 24
Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
journal, February 2015
- Meng, Huan; Wang, Meiying; Liu, Huiyu
- ACS Nano, Vol. 9, Issue 4, p. 3540-3557
Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy
journal, February 2016
- Chang, Danfeng; Gao, Yongfeng; Wang, Lijun
- Journal of Colloid and Interface Science, Vol. 463
Controlled release and intracellular protein delivery from mesoporous silica nanoparticles
journal, December 2016
- Deodhar, Gauri V.; Adams, Marisa L.; Trewyn, Brian G.
- Biotechnology Journal, Vol. 12, Issue 1